Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
11/2003
11/04/2003US6642237 Inhibitors of HIV protease and inhibitors of HIV replication, used in the prevention or treatment of infection by HIV and treatment for AIDS
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
10/2003
10/31/2003WO2002085909A1 9-deazaguanine derivatives as inhibitors of gsk-3
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089437A1 A trifluoroacetic acid process to prepare [2,3-b]pyridine intermediates
10/30/2003WO2003089416A1 Substituted pyrimidine-2,4(1h,3h)-diones for use as matrix metalloproteinase (mmp) inhibitors
10/30/2003WO2003053330A3 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3
10/30/2003WO2003034997A3 Modulators of phosphoinositide 3-kinase
10/30/2003US20030203927 Thrombin receptor antagonists
10/30/2003US20030203909 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents
10/30/2003US20030203860 Substituted sugar derivatives of indolopyrrolocarbazoles, useful in inhibiting the proliferatin of tumor cells
10/30/2003US20030201713 Design and synthesis of advanced NLO materials for electro-optic applications
10/29/2003EP1357163A1 Reactive mesogenic benzodithiophenes
10/29/2003EP1357114A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP)
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355886A1 Fused heterocyclic compounds
10/29/2003EP1355649A2 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
10/29/2003EP1150964B1 Polycyclic pyrimidine-2,4(1h, 3h)-dione with functionalized alkyl radicals in 1- and/or 3-position, method for the production thereof and pharmaceutical preparations
10/29/2003EP1147112B1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
10/29/2003CN1452624A Hydropyridine deriv. acid addition salts
10/29/2003CN1452623A 4-phenyl substd. tetrahydroisoquinolines and therapeutic use thereof
10/29/2003CN1452604A Method for hydrogenating C-C double bonds
10/28/2003US6639023 Fluorophenyl resin compounds
10/28/2003US6638929 Tricyclic protein kinase inhibitors
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086464A1 Preventives/remedies for hotflash
10/23/2003WO2003016248A3 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
10/23/2003US20030199572 Use as pesticides and herbicides
10/23/2003US20030199553 Antidiabetic agents
10/23/2003US20030199531 Biodegradation-resistant mimics of pentapeptide tyrosine-isoleucine-glycine-serine-arginine (YIGSR) binding site for laminin binding protein
10/23/2003US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors
10/23/2003CA2481391A1 Preventives/remedies for hotflash
10/23/2003CA2480856A1 Substituted aryl amides
10/22/2003EP1354884A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1353928A2 Process for preparing clopidogrel
10/22/2003EP1353927A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1043977B1 Oral pharmaceutical pulsed release dosage form
10/22/2003EP0927184B1 3-substituted pyrido 4',3':4,5]thieno 2,3-d]pyrimidine derivatives, their preparation and their use
10/22/2003EP0800519B1 Steroid receptor modulator compounds and methods
10/22/2003CN1451010A Benzosulfones with calcium antagonist activity
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/22/2003CN1124847C Method for treating excessive aggression
10/21/2003US6635770 Process for producing hexahydrothieno (3,4-D)immidazole-2,4-diones
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635763 From 2-chlorobenzaldehyde and cyanide compound, then amine; resolution of racemic mixture
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635642 Poly(ADP-ribose) polymerase inhibitors; tissue damage treatment
10/16/2003WO2003084962A1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084961A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084959A1 Thiopene-based tricyclic compounds and pharmaceutical compositions comprising same
10/16/2003WO2003084947A1 4,5,6,7-tretrahydrobenzo[b] thiophene derivatives and methods for medical intervention against mycrobacterial infections
10/16/2003WO2003084610A1 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
10/16/2003WO2003050064A3 Mitotic kinesin inhibitors
10/16/2003US20030195361 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
10/16/2003US20030195199 Pancreatic lipase inhibitor compounds, their synthesis and use
10/16/2003US20030195188 Pyridine and quinoline derivatives
10/16/2003US20030194698 E2 displacement assay for identifying inhibitors of HPV
10/16/2003CA2481850A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003CA2481514A1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003CA2478227A1 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
10/15/2003EP1352918A1 Alkylenedioxythiophenes and poly(alkylenedioxythiophene)s with side groups containing urethane groups
10/15/2003EP1351962A2 Thienopyrimidine
10/14/2003US6632807 (2R,4S)-(−)-[N-(4-diethoxyphosphorylmethyl)phenyl]-1,2,4,5- tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo-3-benzothiepin-2-carboxamide
10/14/2003US6632418 Radioligands and their use for identifying potassium channel modulators
10/09/2003WO2003082877A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003WO2003082832A2 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003WO2003082828A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003WO2003082593A1 Optical recording media and dipyrromethene-metal chelate compounds
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082264A1 Pharmaceutical composition for preventing or treating respiratory disease
10/09/2003WO2002074056A3 Allosteric adenosine receptor modulators
10/09/2003US20030191142 Induce immunology response; antiinflammatory agents; autoimmune disease
10/09/2003US20030190680 Photocleavable bioreactive agents
10/09/2003CA2480869A1 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003CA2480054A1 Pharmaceutical composition for preventing or treating respiratory disease
10/09/2003CA2479932A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003CA2479930A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/08/2003EP1349861A1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
10/08/2003EP1349858A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1349836A2 Tetracyclic derivatives as spla2 inhibitors
10/08/2003EP1140934B1 Benzisoxazoles and phenones as alpha-2-antagonists
10/08/2003CN1447803A Hyperpolarizable organic chromophores
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/07/2003US6630594 Spiro-pyran compounds; use as pesticides and herbicides
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003CA2229233C Synthesis of hydroxysulfone and related compounds
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080624A2 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
10/02/2003WO2003080596A2 Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides
10/02/2003WO2003016316A8 Diazacycloalkanes as oxytocin agonists
10/02/2003US20030187260 Thienopyrimidines
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187014 Condensed pyrazole derivatives, process for producing the same and use thereof
10/02/2003US20030186995 Substituted bicyclic derivatives useful as anticancer agents
10/02/2003US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
1 ... 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 ... 214